Quantum BioPharma Ltd.
QNTM
$3.89
-$0.16-3.95%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -58.11% | 43.54% | -38.98% | -197.35% | -350.60% |
| Total Depreciation and Amortization | -1.77% | 14.72% | 20.28% | 3.36% | 7.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 286.06% | 165.55% | 454.44% | 15,252.05% | 965.83% |
| Change in Net Operating Assets | -1,261.08% | -91.15% | 244.76% | -146.57% | 151.09% |
| Cash from Operations | 60.84% | 63.44% | 50.26% | -221.37% | -115.91% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -114.29% | -71.81% | 111.79% | -284.41% | -6,009.50% |
| Cash from Investing | -114.29% | -71.81% | 111.79% | -284.41% | -6,009.50% |
| Total Debt Issued | -12.14% | -98.90% | 189.70% | 12,245.28% | 984.32% |
| Total Debt Repaid | -4,284.98% | -2,446.64% | -121.74% | -5,510.27% | -58.50% |
| Issuance of Common Stock | 11,655.34% | -77.25% | -100.00% | -92.09% | -84.51% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 123.35% | -42.68% | -96.12% | -30.09% | 450.99% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 198.35% | -49.25% | -464.16% | -202.24% | -73.65% |